Xidian Pharmaceutical announced that the company recently received the “Notice of Acceptance” for potassium chloride granules issued by the State Drug Administration, and the State Drug Administration decided to accept them after review. The drug is classified as a chemical drug. The specification is 1.5 g of potassium chloride per bag. The application matters are supplementary applications for domestically produced drugs and changes in the subject of drug marketing license holders. As of the date of disclosure of the announcement, 43 domestic companies had obtained approval for the registration of potassium chloride pellets.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.